[1] Northway WH Jr,Rosan RC,Porter DY.Pulmonarydisease following respiratortherapy of hyaline-membrane disease:Bronchopulmonary dysplasia[J].Engl J Med,1967,276(7):357-368.
[2] Jobe AJ.The new BPD:an arrest of lung development[J].Pediatr Res,1999,46(6):641-643.
[3] Jobe AH,Bancalari E.Bronchopulmonary dysplasia[J].Am J RespirCrit Care Med,2001,163(7):1723-1729.
[4] Lemons JA,Bauer CR,Oh W.Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network,January 1995 through December 1996.NICHD Neonatal Research Network[J].Pediatrics,2001,107(1):E1.
[5] Demirel N,Bas AY,Zenciroglu A.Bronchopulmonary dysplasia in very low birth weight infants[J].Indian J Pediatr,2009,76(7):695-698.
[6] 早产儿支气管发育不良调查协作组.早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J].中华儿科杂志,2011,49(9):622-655.
[7] Husain AN,Siddiqui NH,Stocker JT.Pathology of arrested acinar development in postsurfactantbronchopulmonary dysplasia[J].Hum Pathol,1998,29(7):710-717.
[8] Hadchouel A,Durrmeyer X,Bouzigon E,et al.Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia[J].Am J RespirCrit Care Med,2011,184(10):1164-1170.
[9] 甘新莲,张建华,潘初,等.新生儿支气管肺发育不良的影像学表现(附21例分析)[J].放射学实践,2003,18(12):858-860.
[10] Shin SM,Kim WS,Cheon JE.Bronchopulmonary dysplasia:new high resolution computed tomography scoring system and correlation between the high resolution computed tomography score and clinical severity[J].Korean J Radiol,2013,14(2):350-360.
[11] Rocha G,Proenξa E,Areias A,et al.HLA and bronchopulmonary dysplasia susceptibility:a pilot study[J].Dis Markers,2011;31(4):199-203.
[12] 常立文,新生儿支气管肺发育不良诊治进展[J].临床儿科杂志,2007,25(3):161-165.
[13] Bancalari E,Claure N,Sosenko IR.Bronchopulmonary dysplasia:changes in pathogenesis,epidemiology and definition[J].Semin Neonatol,2003,8(1):63-71.
[14] Eriksson L,Haglund B,Odlind V,et al.Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia[J].Pediatr Pulmonol,2014,49(7):665-672.
[15] 薛辛东,刘子云.高危早产儿支气管肺发育不良早期监测及其临床意义[J].中国实用儿科杂志,2014,29(1):7-11.
[16] Popova AP,Bentley JK,Cui TX,et al.Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia[J].Am J Physiol Lung Cell Mol Physiol,2014,307(3):L231-239.
[17] 袁世新.应用条件Logistic回归分析探讨早产的危险因素[J].华中科技大学学报:医学版,2010,39(4):547-549,553.
[18] Guimares H,Guedes MB,Rocha G,et al.Vitamin A in prevention of bronchopulmonary dysplasia[J].Curr Pharm Des,2012,18(21):3101-3113.
[19] Turner MA,Jacqz-Aigrain E,Kotecha S.Azithromycin,Ureaplasma and chronic lung disease of prematurity:a case study for neonatal drug development[J].Ach Dis Child,2012,97(6):573-577.
[20] Bhandari V.Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia[J].Birth Defects Res A Clin Mol Teratol,2014,100(3):189-201.
[21] Vendettuoli V,Bellù R,Zanini R,et al.Changes in ventilator strategies and outcomes in preterm infants[J].Arch Dis Child Fetal Neonatal Ed,2014,99(4):F321-324.
[22] Wunsch H,Mapstone J,Takala J.High-frequency ventilation versus conventional ventilation for the treatment of acute lung injury and acute respiratory distress syndrome:a systematic review and cochrane analysis[J].Anesth Analg,2005,100(6):1765-1772.
[23] 杜立中.早产儿支气管肺发育不良防治新理念[J].中国实用儿科杂志,2014,29(1):12-15.
[24] Chang YS,Ahn SY,Yoo HS,et al.Mesenchymal stem cells for bronchopulmonary dysplasia:phase 1 dose-escalation clinical trial[J].J Pediatr,2014,164(5):966-972.e6.
[25] Bhandari A,McGrath-Morrow S.Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia[J].Semin Perinatol,2013,37(2):132-137.
[26] 张维溪,张海邻,林振浪,等.支气管肺发育不良8例患儿6年临床随访[J].中国循证儿科杂志,2012,07(1):55-58.